https://scholars.lib.ntu.edu.tw/handle/123456789/579295
標題: | Afatinib combined with cetuximab for lung adenocarcinoma with leptomeningeal carcinomatosis | 作者: | Lin C.-H. Lin M.-T. YAO-WEN KUO CHAO-CHI HO |
公開日期: | 2014 | 出版社: | Elsevier Ireland Ltd | 卷: | 85 | 期: | 3 | 起(迄)頁: | 479-480 | 來源出版物: | Lung Cancer | 摘要: | We report a patient with non-small cell lung cancer (NSCLC) developed leptomeningeal carcinomatosis (LMC) after 4 years of multiple treatments. High-dose tyrosine kinase inhibitor (TKI) was given for LMC at first but was not effective. She then received dual therapy combining of afatinib and cetuximab. Brain magnetic resonance imaging (MRI) showed a partial response of disease and the patient experienced a clinical benefit. Our case suggests that dual targeting of epidermal growth factor receptor (EGFR) by a combination of afatinib and cetuximab can be a potential novel treatment option in treating LMC when high-dose TKI failed. ? 2014 Elsevier Ireland Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926420126&doi=10.1016%2fj.lungcan.2014.06.002&partnerID=40&md5=6d7dbda7c83b515089e8bbaaa1b6a5c1 https://scholars.lib.ntu.edu.tw/handle/123456789/579295 |
ISSN: | 0169-5002 | DOI: | 10.1016/j.lungcan.2014.06.002 | SDG/關鍵字: | afatinib; bevacizumab; cetuximab; cisplatin; docetaxel; epidermal growth factor receptor; erlotinib; gefitinib; gemcitabine; paclitaxel; pemetrexed; protein tyrosine kinase inhibitor; afatinib; antineoplastic agent; cetuximab; epidermal growth factor receptor; monoclonal antibody; quinazoline derivative; adult; anisocoria; Article; brain metastasis; cancer chemotherapy; cancer radiotherapy; carcinomatous meningitis; case report; cytology; disease course; drug megadose; drug pulse therapy; dyspnea; female; headache; human; lung adenocarcinoma; neuroimaging; non small cell lung cancer; nuclear magnetic resonance imaging; pleura effusion; priority journal; treatment response; adenocarcinoma; brain; fatality; genetics; Lung Neoplasms; Meningeal Carcinomatosis; Meningeal Neoplasms; mutation; Neoplasms, Second Primary; pathology; secondary; Adenocarcinoma; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Brain; Fatal Outcome; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Meningeal Carcinomatosis; Meningeal Neoplasms; Mutation; Neoplasms, Second Primary; Quinazolines; Receptor, Epidermal Growth Factor |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。